To see the other types of publications on this topic, follow the link: Fibrocystic mastopathy.

Journal articles on the topic 'Fibrocystic mastopathy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Fibrocystic mastopathy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Смоланка, І. І., А. О. Ляшенко, А. О. Ляшенко, and А. О. Ляшенко. "Fibrocystic mastopathy." Reproductive Endocrinology, no. 18 (November 17, 2014): 17. http://dx.doi.org/10.18370/2309-4117.2014.18.17-23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Guseynov, Arif. "FIBROCYSTIC MASTOPATHY." Clinical Medicine and Pharmacology 6, no. 3 (2020): 19–32. http://dx.doi.org/10.12737/2409-3750-2020-6-3-19-32.

Full text
Abstract:
The lecture provides information for specialist doctors: oncologists, surgeons, mammologists, general practitioners on the diagnosis and treatment of fibrocystic mastopathy. The current data on the etiology and pathogenesis, classification and clinic of the disease are presented, well-known and new diagnostic methods, advantages and disadvantages of each method are described in detail. Issues of differential diagnostics are highlighted, optimal tactics, methods of conservative and surgical treatment are proposed
APA, Harvard, Vancouver, ISO, and other styles
3

Guseynov, Arif, and M. D'yakov. "ASSESSMENT OF THE EFFECTIVENESS OF YOUNG MASTON IN THE CONSERVATIVE TREATMENT OF FIBROCYSTIC MASTOPATHY IN WOMEN OF REPRODUCTIVE AGE." Clinical Medicine and Pharmacology 10, no. 1 (2024): 2–5. http://dx.doi.org/10.12737/2409-3750-2024-10-1-2-5.

Full text
Abstract:
The paper presents modern approaches to drug therapy for the most common pathology of the mammary glands – fibrocystic mastopathy. The most effective method of conservative treatment of fibrocystic mastopathy in patients of reproductive age is herbal medicine using drugs with anti-estrogenic effects. The indications were determined and the pharmacological action and effectiveness of the drug Mladomaston were assessed. It has been shown that with a 3-month course of administration, the drug provides sufficient effectiveness, expressed primarily in the reduction of pain in the mammary glands and
APA, Harvard, Vancouver, ISO, and other styles
4

Yeszhan, B. G., and S. O. Ossikbayeva. "Study of danazol active agent effect on Mcf10a breast cells redox phosphorylation." Oncologia i radiologia Kazakhstana 60, no. 2 (2021): 32–35. http://dx.doi.org/10.52532/2663-4864-2021-2-60-32-35.

Full text
Abstract:
Fibrocystic mastopathy is one of the most complex breast pathologies, occurring in about 60% of women. The causes and molecular mechanisms of cyst formation in fibrocystic mastopathy are not fully understood, and effective treatment methods are not widely implemented. However, there is evidence of the fibrocystic mastopathy malignization risk. We studied the molecular effect of the active agent danazol on the respiratory complex in mitochondria, which occur in various concentrations and are considered the cell energy center.
 A method of permeation with special agents was developed to imp
APA, Harvard, Vancouver, ISO, and other styles
5

Yeszhan, B. G., and S. O. Ossikbayeva. "Study of danazol active agent effect on Mcf10a breast cells redox phosphorylation." Oncologia i radiologia Kazakhstana 60, no. 2 (2021): 32–35. http://dx.doi.org/10.52532/2521-6414-2021-2-60-32-35.

Full text
Abstract:
Relevance: Fibrocystic mastopathy is one of the
 most complex breast pathologies, occurring in about
 60% of women. The causes and molecular mechanisms of cyst formation in fibrocystic mastopathy are
 not fully understood, and effective treatment methods are not widely implemented. However, there is
 evidence of the fibrocystic mastopathy malignization
 risk. We studied the molecular effect of the active agent
 danazol on the respiratory complex in mitochondria,
 which occur in various concentrations and are considered the cell energy center.
 A method o
APA, Harvard, Vancouver, ISO, and other styles
6

Ustimov, D. Yu. "On the question of psychogenic factors in the pathogenesis of dyshormonal focal breast diseases." Neurology Bulletin XXXV, no. 1-2 (2003): 50–51. http://dx.doi.org/10.17816/nb89670.

Full text
Abstract:
The successes of psychosomatic medicine have led to the identification of a connection between psychotraumatic factors and diseases such as stomach ulcers, bronchial asthma, hypertension, etc. Psychotropic drugs and psychotherapy have long been used in the complex therapy of these diseases. However, in the treatment of dyshormonal mastopathy (fibroadenosis, nodular fibrocystic mastopathy, fibrotizing adenosis), hormone therapy and surgery still dominate. Meanwhile, the connection between dyshormonal mastopathy and the mental sphere of patients is obvious, but little studied.
APA, Harvard, Vancouver, ISO, and other styles
7

Khomasuridze, A. G., R. A. Manusharova, and N. G. Marsaghishvili. "Use of long-acting contraceptives in therapy of mastopathy." Problems of Endocrinology 40, no. 5 (1994): 29–30. http://dx.doi.org/10.14341/probl12165.

Full text
Abstract:
Effects of long-acting contraceptives on mammary glands of patients with diffuse fibrocystic mastopathy were under study. A total of 206 women aged 17 to 38 were examined. In 50 of them fibrocystic mastopathy was detected by palpation, noncontrast mammography, and ultrasonic examination. On days 5-7 of the cycle the patients were injected 1 ml of depot prover or noristerate or subcutaneously implanted norplant. Injections of the two former agents were repeated in 3 months if necessary. Control examinations were carried out 3 months to 5 years after the contraceptives were started. The results
APA, Harvard, Vancouver, ISO, and other styles
8

Anisimova, Svetlana A., Janna A. Svirina, and Denis A. Maksaev. "Modeling of fibrocystic mastopathy in experiment on animals." I.P. Pavlov Russian Medical Biological Herald 28, no. 4 (2020): 429–36. http://dx.doi.org/10.23888/pavlovj2020284429-436.

Full text
Abstract:
Nowadays, hormonal imbalance is proven to be a factor that influences initiation of malignant and benign breast tumors. To study the aspects of participation of sex hormones in damage to organs and tissues, it may be necessary to model a common womens pathology fibrocystic disease of mammary glands characterized by the most pronounced effects of this pathogenetic factor, on experimental animals.
 Aim. To create a model of fibrocystic disease of mammary gland with the subsequent possibility of studying morphological manifestations of the disease in natural and drug-induced pathomorphism.&#
APA, Harvard, Vancouver, ISO, and other styles
9

Marcu, Daniela Andreea, and Emese Orban. "Fibrocystic mastopathy: a diagnosis and therapeutic challenge." Medic.ro 2, no. 140 (2021): 28. http://dx.doi.org/10.26416/med.140.2.2021.4929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Smolanka, I. I., and A. D. Loboda. "Modern view on treatment of patients with fibrocystic mastopathy." HEALTH OF WOMAN, no. 6(112) (July 29, 2016): 149–52. http://dx.doi.org/10.15574/hw.2016.112.149.

Full text
Abstract:
The aim of the study: to determine the effectiveness of the drug Epigalin® Brest in the treatment of fibrocystic breast disease in women. Materials and methods. The study included 50 women with an established diagnosis of fibrocystic breast disease (diffuse cystic mastopathy). All women complained of pain and swelling of both breast 3-20 days before the start of menstruation. By blind randomization, all women were divided into 2 groups. Patients of the first group used the drug Epigalin® Brest 1 tablet 2 times a day for three months. Patients of the second group used the drug prostrate summer
APA, Harvard, Vancouver, ISO, and other styles
11

Rubashkina, А. N., O. A. Gromova, and I. Yu Torshin. "Lignans and other components of phytoextracts for the treatment of fibrocystic mastopathy." Voprosy dietologii 14, no. 1 (2024): 47–53. http://dx.doi.org/10.20953/2224-5448-2024-1-47-53.

Full text
Abstract:
Objective. Comparative analysis of data on various plant extracts and their components, characterized by antitumor and antiinflammatory effects. Materials and methods. Systematic data analysis using topological recognition theory methods, clinical study of patients with fibrocystic mastopathy (FCM). Results. The analysis showed that the anti-inflammatory, antioxidant and antitumor properties of extracts of oleander, hauttuynia cordata, mistletoe, bitter melon, ginkgo biloba, grape seeds, cohosh, chasteberry and common spruce may be useful in the treatment of mastopathy and the prevention of br
APA, Harvard, Vancouver, ISO, and other styles
12

Borovikov, I. O., I. I. Kutsenko, V. P. Bulgakova, and O. I. Borovikova. "Non-hormonal therapy of patients with fibrocystic mastopathy in combination with endometrial hyperplasia." Meditsinskiy sovet = Medical Council, no. 21-1 (January 7, 2022): 182–89. http://dx.doi.org/10.21518/2079-701x-2021-21-1-182-189.

Full text
Abstract:
Introduction. The article presents a comparative analysis of the treatment of patients with combined estrogen-dependent pathology of female reproductive system: fibrocystic mastopathy and endometrial hyperplasia without atypia. The experience of treatment with an indole-carbinol-containing drug as monotherapy while using a levonorgestrel-releasing intrauterine system is presented.Aim. To evaluate the clinical efficacy of indolecarbinol in the treatment of patients with combined estrogen-dependent pathology of the female reproductive system.Materials and methods. The authors studied the respons
APA, Harvard, Vancouver, ISO, and other styles
13

Boopathy, Teleflo, S. Kanimozhi, V. Ramya, and P. Lakshmi Piriya. "Lymphocytic Mastitis with Fibroadenoma – A Case Report." Journal of Medical Sciences and Health 9, no. 1 (2023): 118–20. http://dx.doi.org/10.46347/jmsh.v9i1.22.374.

Full text
Abstract:
Diabetic mastopathy is an uncommon fibrous tissue lesion of the breast which is usually seen in patients with longstanding type 1 diabetes mellitus. We report a case of diabetic mastopathy in an insulin dependent type 2 diabetes mellitus patient. 47-year-old postmenopausal woman, presented with two lumps, one firm mobile mass and another, a firm-hard mass in the upper inner quadrant of the left breast. Mammography and ultrasonography came out to be BIRADS III lesion. Fine-needle aspiration cytology [FNAC] was performed showing features of fibroadenoma with fibrocystic change. Histopathological
APA, Harvard, Vancouver, ISO, and other styles
14

Musina, E. V., and I. Y. Kogan. "The effect of Metformin on fibrocystic breast disease in women with insulin resistance." Tumors of female reproductive system 14, no. 3 (2018): 19–24. http://dx.doi.org/10.17650/1994-4098-2018-14-3-19-24.

Full text
Abstract:
A little studied question is the development mechanism, timely diagnostics, treatment and prevention of the fibrocystic breast disease at patients with insulin resistance. One of the possible perspective directions of pathogenetic impact on tissues of a mammary gland at the mastopathy associated with a giperinsulinemiya and insulin resistance is use of metformin. Now clinical trials on use of metformin at cancer of mammary glands continue. Data on use of medicines of this group at patients with fibrocystic breast disease in domestic and foreign literature are absent.Objective:assessment of inf
APA, Harvard, Vancouver, ISO, and other styles
15

Раннева, L. Ranneva, Хадарцева, K. Khadartseva, Силаева, and E. Silaeva. "Pelvic Inflammatory Disease and Fibrocystic Breast Diseases (brief report)." Journal of New Medical Technologies 20, no. 4 (2013): 69–71. http://dx.doi.org/10.12737/2732.

Full text
Abstract:
This report presents the results of clinical and laboratory examination of 200 women living in rural areas of the Tula region, which were examined mammalogist and gynecologist when conducting cytological study. It was revealed 54.5% of women with various pathology of mammary glands, 40% - with benign tumors of the uterus, 8.1% of chronic salpingo-oophoritis, 10.8% - with erosion of cervix of the uterus. According to the gynecological examination results are as follows: 25% - gynecological diseases, obesity -58%, pathology from the side of the cervical in 30%, prolapse of the vaginal walls - in
APA, Harvard, Vancouver, ISO, and other styles
16

Zavizion, V. F. "Fibrocystic changes of the mammary glands: interpretation of the diagnosis, issues of diagnosis and treatment (Literature review)." Reproductive health of woman, no. 2 (March 29, 2024): 96–102. http://dx.doi.org/10.30841/2708-8731.2.2024.304668.

Full text
Abstract:
In the Ukrainian-language medical literature there is very little correct information about benign changes in the mammary glands, publications mostly date from the eighties of the last century – the beginning of the current one. This article is a review of modern scientific domestic and foreign sources, which are devoted to the problem of benign changes of the mammary glands and recommendations for their treatment, which are based on the evidence base. The article analyzes 40 publications, mostly by foreign scientists.The prevalence of non-neoplastic changes in the mammary glands, which in mos
APA, Harvard, Vancouver, ISO, and other styles
17

V.F., Zavizion. "Fibrocystic changes of the mammary glands: interpretation of the diagnosis, issues of diagnosis and treatment (Literature review)." Reproductive Health of Woman, no. 2 (March 29, 2024): 96–102. https://doi.org/10.30841/2708-8731.2.2024.304668.

Full text
Abstract:
In the Ukrainian-language medical literature there is very little correct information about benign changes in the mammary glands, publications mostly date from the eighties of the last century – the beginning of the current one. This article is a review of modern scientific domestic and foreign sources, which are devoted to the problem of benign changes of the mammary glands and recommendations for their treatment, which are based on the evidence base. The article analyzes 40 publications, mostly by foreign scientists.The prevalence of non-neoplastic changes in the mammary glands, which
APA, Harvard, Vancouver, ISO, and other styles
18

Musina, Ekaterina V., Igor Yu Kogan, and Natalia V. Borovik. "The condition of mammary glands in women with diabetes mellitus type 1." Journal of obstetrics and women's diseases 67, no. 3 (2018): 38–43. http://dx.doi.org/10.17816/jowd67338-43.

Full text
Abstract:
Background. The pathogenesis of diabetic mastopathy is unknown. It is assumed that one of the important factors in the development of this disease may be hyperglycemia.
 The aim of this study was to evaluate the clinical manifestations and echographic features of the mammary gland structure in women with diabetes mellitus type 1.
 Materials and methods. The three groups of women were examined: group 1: women with type 1 diabetes, with the onset of the disease before menarche (n = 58); group 2: women with type 1 diabetes, with the onset of the disease after menarche (n = 56); group 3:
APA, Harvard, Vancouver, ISO, and other styles
19

Shabaev, R. M., I. V. Kolyadina, D. A. Blagovestnov, and P. M. Starokon. "Clinical and radiological efficacy of a new conservative treatment for fibrocystic disease." Tumors of female reproductive system 19, no. 4 (2024): 36–42. http://dx.doi.org/10.17650/1994-4098-2023-19-4-36-42.

Full text
Abstract:
Background. Long-lasting dyshormonal breast diseases in women represent a risk factor for breast cancer, especially in patients with atypia. Clinical manifestations of fibrocystic breast disease (FBD) and mastopathy, including high-intensity pain cause psychoemotional discomfort and reduce the quality of life of women. The search for effective management strategies for mastopathy with an antiproliferative effect is highly relevant.Aim. To assess clinical and radiological efficacy of a new conservative treatment for FBD, “Evening primrose oil” administered orally for 6 months in women with symp
APA, Harvard, Vancouver, ISO, and other styles
20

Chantra, P. K., J. T. Tang, T. M. Stanley, and L. W. Bassett. "Circumscribed fibrocystic mastopathy with formation of an epidermal cyst." American Journal of Roentgenology 163, no. 4 (1994): 831–32. http://dx.doi.org/10.2214/ajr.163.4.8092018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Yenen, M. C., M. Dede, U. Goktolga, T. Kuçuk, and R. Pabuçcu. "Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy." Climacteric 6, no. 2 (2003): 146–50. http://dx.doi.org/10.1080/cmt.6.2.146.150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Yenen, M. C., M. Dede, U. Goktolga, T. Kuçuk, and R. Pabuçcu. "Hormone replacement therapy in postmenopausal women with benign fibrocystic mastopathy." Climacteric 6, no. 2 (2003): 146–50. http://dx.doi.org/10.1080/713605375.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Ю., Я. Присташ. "Hormonal status of patients after surgical treatment of fibrocystic mastopathy." Reproductive Endocrinology, no. 44 (December 28, 2018): 36–39. https://doi.org/10.18370/2309-4117.2018.44.36-39.

Full text
Abstract:
The purpose of the study was to investigate the efficacy of Mastodynon® in terms of indications in elevated doses versus the standard dose. Materials and methods. Data were analyzed for 60 patients after surgical treatment of fibrocystic mastopathy. Depending on the postoperative therapy received by the patients, they were divided into three equal groups. Patients of Group I were observed in accordance with the standards established in mammal practice and did not receive special agents that affect hormonal homeostasis. Patients of Group II in addition to observation received Mastodynon&reg
APA, Harvard, Vancouver, ISO, and other styles
24

Mahmadiyorova, Ziyoda. "Mastopathy." МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ: ТЕОРИЯ И ПРАКТИКА 1, no. 1 (2023): 18–20. https://doi.org/10.5281/zenodo.8384999.

Full text
Abstract:
<em>In a world filled with uncertainty, the journey of understanding and demystifying medical conditions like Mastopathy offers a glimmer of hope and reassurance. This thesis embarks on a compassionate exploration of Mastopathy, seeking to shed light on this complex breast disorder. Through meticulous research, insightful analysis, and a commitment to empowering individuals, this work extends a comforting hand to those who may have encountered the challenges posed by Mastopathy.</em>
APA, Harvard, Vancouver, ISO, and other styles
25

Radowicki, S., and M. Kunicki. "Prostate specific antigen in women with menstrual disturbances and fibrocystic mastopathy." Journal of Endocrinological Investigation 32, no. 10 (2009): 821–24. http://dx.doi.org/10.1007/bf03345752.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Rubashkina, Anna N., Nina P. Lapochkina, Ivan Yu Torshin, and Olga A. Gromova. "The role of 7-hydroxymatairezinol in modulation of estrogen metabolism and therapy for mastopathy." Gynecology 22, no. 4 (2020): 43–48. http://dx.doi.org/10.26442/20795696.2020.4.200183.

Full text
Abstract:
Quantitative estimates of the effect of 7-hydroxymatairesinol (7-HMR) intake on estrogen balance and clinical aspects of the course of fibrocystic mastopathy have been carried out.&#x0D; Aim. Assessment of effects 7-HMR on metabolism of estrogen (16a-OHE1, 2-OHE2, 2-OHE1, 2-OMEE1, 4-OMEE2, 4-OHE1, a ratio 2-OHE1/16a-OHE1, 2-OHE1/2-OMeE1 and 4-OHE1/4-OMeE1) and progesterone in daily urine at patients with fibrous and cystous mastopathy in the post-menopausal period.&#x0D; Materials and methods. The analysis of metabolites of estrogen (16a-OHE1, 2-OHE2, 2-OHE1, 2-OMEE1, 4-OMEE2, 4-OHE1, ratios 2
APA, Harvard, Vancouver, ISO, and other styles
27

Musina, Ekaterina V., and Igor Yu Kogan. "Application possibilities of biguanides for fibrocystic breast disease in women of reproductive age." Journal of obstetrics and women's diseases 68, no. 3 (2019): 35–40. http://dx.doi.org/10.17816/jowd68335-40.

Full text
Abstract:
Hypothesis/aims of study. The ongoing global problem of health care and medical science is an associated increase in the frequency of endocrine and metabolic diseases and cancer, including in women of childbearing age. Thus, the frequency of diabetes in the population has been growing rapidly for many years. Similar trends were observed in the dynamics of the frequency of cancer pathology, especially of breast cancer, which is one of the leading places in the structure of the cancer incidence in the female population. It is known that diabetes and related insulin resistance have a very negativ
APA, Harvard, Vancouver, ISO, and other styles
28

Topchubaeva, T., R. Tukhvatshin, Hossain Ashfaque, Sainul Hossain Mohammad, Musharaf Parvej, and A. Kudaiarova. "Reasons and Mechanisms of Development of Mastopathy (Review of Literature)." Bulletin of Science and Practice 10, no. 1 (2024): 154–61. http://dx.doi.org/10.33619/2414-2948/98/21.

Full text
Abstract:
This review article examines the relationship between various etiological factors in the development of mastopathy. Multiple exogenous and endogenous risk factors disrupt the normal ratio of sex hormones, causing hyperestrogenism and hyperproliferation of the epithelium in breast tissue, which leads to the development of mastopathy. In the presence of polymorphism of coding genes (ESR1 and PRG), mastopathy also increases the risk of developing breast cancer. Disturbances in the ESR1 receptor gene (Estrogen Receptor 1) lead to changes in the sensitivity of receptors to hormones and even to its
APA, Harvard, Vancouver, ISO, and other styles
29

Khomutenko, V. L., and D. D. Bilyi. "Argumentation of the complex scheme for diagnosis and treatment of mastopathy in dogs." Theoretical and Applied Veterinary Medicine 12, no. 3 (2024): 18–28. https://doi.org/10.32819/2024.12013.

Full text
Abstract:
Over the past 3 years, a 1.7-fold increase in the incidence of cystic fibrosis in bitches has been recorded. Currently, the problems of early diagnosis of mastopathy and effective treatment of mastopathy, which is one of the ways to reduce the incidence of mammary gland tumors in bitches, have become particularly relevant. The purpose of the research was the development and clinical approval of schemes for complex diagnosis and treatment of bitches with mastopathy. The clinical significance and relationship of the diagnostic criteria for mastopathy in bitches was determined, which became the b
APA, Harvard, Vancouver, ISO, and other styles
30

Burdina, I. I., S. B. Zapirova, N. I. Rozhkova, et al. "Combined conservative treatment of breast cysts after cosmetic endoprosthesis." Medical Science And Education Of Ural 21, no. 3 (2020): 6–11. http://dx.doi.org/10.36361/1814-8999-2020-21-3-6-11.

Full text
Abstract:
The aim: study of the effectiveness of the combined treatment of cysts in women after cosmetic breast endoprosthesis with the help of ozone therapy and drug Mastodinon. Material and methods. For 1.5 years with dynamic control after 6-12 months. clinical-x-ray-sonographic examination of the mammary glands of 21 women aged 34 to 42 years with different variants of mastopathy and cysts after cosmetic endoprosthesis was carried out. For therapeutic purposes, a fine needle aspiration biopsy of breast cysts was performed under ultrasound control, followed by the introduction of an ozone-oxygen mixtu
APA, Harvard, Vancouver, ISO, and other styles
31

Pryshash, Yu Ya. "Hormonal status of patients after surgical treatment of fibrocystic mastopathy and possibilityes of its corrections." HEALTH OF WOMAN, no. 5(121) (June 30, 2017): 128–31. http://dx.doi.org/10.15574/hw.2017.121.128.

Full text
Abstract:
The purpose of the study was to investigate the efficacy of Mastodynon in terms of indications in elevated doses versus the standard dose. Materials and methods. Data were analyzed for 60 patients after surgical treatment of fibro-cystic mastopathy. Depending on the postoperative therapy received by the patients, they were divided into three groups. Group I (n = 20): patients were observed in accordance with the standards established in mammal practice and did not receive special agents that affect hormonal homeostasis. Group II (n = 20): In addition to observation, patients received Mastodyno
APA, Harvard, Vancouver, ISO, and other styles
32

Osipova, Lyudmila K., Ekaterina V. Kolesnikova, Alexander V. Zharov, and Milena A. Penzhoyan. "Obstetric, somatic and infectious risk factors for vulva sclerotic lichen." RUDN Journal of Medicine 28, no. 1 (2024): 86–103. http://dx.doi.org/10.22363/2313-0245-2024-28-1-86-103.

Full text
Abstract:
Relevance. Until now, disputes among scientists about its etiology, pathogenesis, nomenclature and risk factors for the development of vulvar lichen sclerosis have not subsided, which actualizes the need for scientific research aimed at solving these problems. The aim of the study - to establish statistically significant clinical and anamnestic risk factors for vulvar lichen sclerosis. Materials and Methods. An electronic database was formed with data from 344 patients with lichen sclerosus of the vulva and 60 women without vulvar diseases aged 20-70 years on hereditary, obstetric-­gynecologic
APA, Harvard, Vancouver, ISO, and other styles
33

Sukhostavets’, Natalia. "Pressing questions of conduct of women with the hyperplastic processes of endometrium on a background fibrocystic mastopathy." Perinatology and reproductology: from research to practice 4, no. 4-2 (2025): 94–98. https://doi.org/10.52705/2788-6190-2024-04.2-14.

Full text
Abstract:
The objective:to promote efficiency of diagnostics and treatment of the united pathology – hyperplastic processes of endometrium and fibrocystic lesion of the mammary glands on the basis of study of clinical-and-echographic, dopplerand endocrinology features, and also improvement of algorithm of diagnostic and treatment-and-prophylactic measures.Materials and methods. Under a supervision there were 230 patients of perimenopausal period with the verified hyperplastic processes of endometrium, the careful inspection of mammary glands is executed in which. To perimenopause took patients from 45 t
APA, Harvard, Vancouver, ISO, and other styles
34

Coelho, Gustavo, Luís Azevedo, Horácio Zenha, Maria da Luz Barroso, Augusta Cardoso, and Horácio Costa. "Dual-Sided Polytetrafluoroethylene mesh in Immediate Prosthetic Breast Reconstruction following Treatment of Severe Fibrocystic Mastopathy." European Journal of Plastic Surgery 35, no. 12 (2012): 891–95. http://dx.doi.org/10.1007/s00238-012-0724-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Bitsadze, V. O., J. Kh Khizroeva, A. G. Solopova, et al. "How to reduce a risk of venous thromboembolism while taking combined oral contraceptives." Obstetrics, Gynecology and Reproduction 17, no. 3 (2023): 332–42. http://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2023.422.

Full text
Abstract:
The review presents data on the evolution of combined oral contraceptives (COCs), related most frequent and dangerous side effects including venous thromboembolism (VTE). The issue of VTE upon administration of COCs is highlighted, and the risks of such complication in patients receiving hormonal contraception are determined. The issues of the basic demands of women choosing COCs are considered as well as current opportunities to meet such requests by using novel drug groups with a high profile of efficacy and safety. Particular cases of optimal COCs choice for patients with specific comorbidi
APA, Harvard, Vancouver, ISO, and other styles
36

Autenshlyus, A. I., A. A. Studenikina, A. V. Bernado, et al. "Assessment of the cytokine-producing resource of tumor biopsy samples from patients with invasive carcinoma of no special type and with non-malignant breast diseases." Biomeditsinskaya Khimiya 65, no. 5 (2019): 418–23. http://dx.doi.org/10.18097/pbmc20196505418.

Full text
Abstract:
Breast cancer, in most cases, is a malignant neoplasm associated with infiltration of a tumor with the cells that form its microenvironment and produce various cytokines. The aim of the study was to evaluate the cytokine-producing function of tumor cells and their microenvironment in biopsy specimen of patients with invasive carcinoma of no special type and in patients with benign breast diseases. To assess the cytokine-producing activity of the tumor and its microenvironment, the index of polyclonal activators influence on cytokine production by biopsy specimens of patients with invasive carc
APA, Harvard, Vancouver, ISO, and other styles
37

Vriese, G. De, J. Bonte, and A. Bossuyt. "Goserelin, an LH-RH Agonist, in the Treatment of Women With Fibrocystic Mastopathy. a Pilot Study." Journal of Obstetrics and Gynaecology 11, no. 4 (1991): 272–76. http://dx.doi.org/10.3109/01443619109027821.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Koreyba, L. V., D. M. Masyuk, P. M. Skliarov, and M. O. Leshchova. "Organopathology of the mammary gland in female carnivores: current state of research issues." Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies 26, no. 113 (2024): 132–39. http://dx.doi.org/10.32718/nvlvet11320.

Full text
Abstract:
The article presents the results of studies on the prevalence of mammary gland lesions in cats and dogs in veterinary hospitals of the city of Dnipro and associated with a wide range of pathological processes. Pathological processes (neoplastic, hyperplastic, inflammatory) in the mammary gland, in case of untimely diagnosis and treatment, give rise to the development of neoplasms, which are mostly malignant and manifest as adenocarcinoma, lymphoma, sarcoma, and carcinoma. Studies of mammary gland organopathology in female carnivores have shown that among mammary gland diseases in female pets,
APA, Harvard, Vancouver, ISO, and other styles
39

Atanesyan, R. A., L. Ja Klimov, T. M. Vdovina, et al. "A clinical case of papillary thyroid cancer associated with a PTEN gene defect." Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 69, no. 6 (2025): 85–90. https://doi.org/10.21508/1027-4065-2024-69-6-85-90.

Full text
Abstract:
The incidence of malignant neoplasms associated with solitary thyroid nodules is higher in children than in adults. The diagnosis of nodular thyroid pathology in pediatric practice clearly requires particular attention. Clinical history should include an assessment of risk factors for malignant tumors and a family history. Thyroid tumors are observed in certain syndromes, such as Carney complex, familial adenomatous polyposis, and Cowden, DICER1, Werner, McCune–Albright, and Li–Fraumeni syndromes. This article presents a case of a highly differentiated thyroid tumor diagnosed in a 15-year-old
APA, Harvard, Vancouver, ISO, and other styles
40

Forte, Angelo, Lidia Santarpia, Piero Venetucci, and Antonio Barbato. "Aorto–mesenteric compass syndrome (Wilkie’s syndrome) in the differential diagnosis of chronic abdominal pain." BMJ Case Reports 16, no. 9 (2023): e254157. http://dx.doi.org/10.1136/bcr-2022-254157.

Full text
Abstract:
A woman in her 40s was admitted to hospital with weight loss, asthenia, persistent abdominal pain and post-prandial nausea and vomiting. Other comorbidities were anxiety-depressive disorder, gastro-oesophageal reflux disease and fibrocystic mastopathy. On admission her body mass index (BMI) was 15.57 kg/m2with a reported weight loss of 6 kg during the last 3 months. The patient underwent a double contrast abdominal CT scan, which showed that the third portion of the duodenum appeared to be compressed between the superior mesenteric artery and the abdominal aorta. After a multidisciplinary eval
APA, Harvard, Vancouver, ISO, and other styles
41

Vizoso, F., MaT Allende, MaC Diez, and A. Ruibal. "Evidence of a Correlation between CA15.3 and Estradiol Serum Levels in Women with Fibrocystic (non Macrocystic) Mastopathy." International Journal of Biological Markers 6, no. 1 (1991): 33–34. http://dx.doi.org/10.1177/172460089100600107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Cortés-Martín, Jonathan, Juan Carlos Sánchez-García, Beatriz Piqueras-Sola, Raquel Rodríguez-Blanque, María Isabel Tovar-Gálvez, and Lourdes Díaz-Rodríguez. "Hajdu-Cheney Syndrome: Report of a Case in Spain." Diagnostics 12, no. 3 (2022): 566. http://dx.doi.org/10.3390/diagnostics12030566.

Full text
Abstract:
This paper describes the case of a 54-year-old woman diagnosed with Hajdu–Cheney syndrome, who presents with characteristic craniofacial dysmorphia, short stature, premature loss of teeth, developmental skeletal disorders, fibrocystic mastopathy, bilateral hearing loss and an intermittent mild neutropenia. The patient received treatment with bisphosphonates and was awaiting evaluation for surgical arthroplasty of both hips when she suffered a motor vehicle accident, which led to a rapid progression in her disease by increasing her degree of dependence for most activities of daily living. The c
APA, Harvard, Vancouver, ISO, and other styles
43

Andreeva, Andreeva E. N., and Rozhkova N. I. Rozhkova. "Efficacy of micronized progesterone-containing transdermal gel in the treatment of fibrocystic mastopathy: Results of a Russian study." Akusherstvo i ginekologiia 12_2016 (December 27, 2016): 131–36. http://dx.doi.org/10.18565/aig.2016.12.131-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Д., Зайдлова-Вуттке, and Вуттке В. "THE PREMENSTRUAL SYNDROME, PREMENSTRUAL MASTODYNIA, FIBROCYSTIC MASTOPATHY AND INFERTILITY HAVE OFTEN COMMON ROOTS. EFFECTS OF EXTRACTS OF CHASTEBERRY (VITEX AGNUS-CASTUS) AS A SOLUTION." REPRODUCTIVE ENDOCRINOLOGY, no. 45 (February 28, 2019): 66–74. https://doi.org/10.18370/2309-4117.2019.45.66-74.

Full text
Abstract:
The dried fruits of the chaste tree Vitex agnus-castus (VAC) were traditionally used by monks as a substitute for pepper and was therefore also called Monk&rsquo;s pepper. For the last 50 years it is commercially provided for the treatment of premenstrual symptoms, particularly to prevent premenstrual mastodynia (mastalgia). Most studies were performed with the preparation containing an aqueous/ethanolic ectract BNO 1095. A number of placebo controlled studies gave proof that extracts of VAC had beneficial effects on premenstrual breast pain. This breast sensation is induced by latent hyperpro
APA, Harvard, Vancouver, ISO, and other styles
45

Zotov, O. S. "Diffusive non-tumoral pathology of the breast: current state of the problem. Diagnosis and treatment of mastalgia." Reproductive Endocrinology, no. 57 (March 31, 2021): 48–53. http://dx.doi.org/10.18370/2309-4117.2021.57.48-53.

Full text
Abstract:
In the twentieth century, a whole teaching of mastopathy was formed. However, over time, accumulated data have questioned the existence of mastopathy as a separate nosological form, because the term “fibrocystic disease” while mastalgia is the most common symptom does not correspond to a holistic concept of the disease. This “disease” can be diagnosed in any woman and more or less successfully treated. In the United States, this term was obsolete in 1985. Instead, the term ANDI (Aberrations in the Normal Development and Involution of the breast) was proposed, which correctly corresponds to the
APA, Harvard, Vancouver, ISO, and other styles
46

Fomina, I. V., S. A. Kosarev, A. G. Kuzmin, K. N. Kostyuchenko, and S. A. Romanenko. "Portrait of a woman receiving a spa treatment." Medical Science And Education Of Ural 22, no. 4 (2021): 126–29. http://dx.doi.org/10.36361/1814-8999-2021-22-4-126-129.

Full text
Abstract:
Aim. To study the structure of somatic and genital pathology of women receiving spa treatment. Materials and methods. On the basis of the Pogranichnik clinical sanatorium, a continuous retrospective study was carried out, covering women who received spa treatment in 2019-2020. The material for the study was 837 case histories of patients. The criteria for inclusion in the study were: the patient’s appeal to an obstetrician-gynecologist in a sanatorium, consent to the examination. Exclusion criteria from the study: absence of examination by an obstetrician-gynecologist in the patient, informed
APA, Harvard, Vancouver, ISO, and other styles
47

В., І. Пирогова, О. Шурпяк С., and Г. Місюра А. "COMPARATIVE EVALUATION OF THE EFFICIENCY OF COMPLEX BIOACTIVE INDOL AND VITEX-CONTAINING MEDICINES IN TREATMENT OF DISHORMONAL DYSPLASIA OF THE MAMMARY GLANDS." REPRODUCTIVE ENDOCRINOLOGY, no. 49 (October 31, 2019): 18–23. https://doi.org/10.18370/2309-4117.2019.49.18-23.

Full text
Abstract:
Purpose of study. Comparison the efficacy of therapy of fibrocystic breast disease (FBD) in women of reproductive age with different complex bioactive indole-containing and vitex-containing drugs. Materials and methods. The study involved 80 patients with FBD who received Epigalin Brest (Group I, 40 women) and Depapillin (Group II, 40 women). Methods of study included anthropometry, hormonal profile, ultrasound examination of the breast and pelvic organs, mastodin score. Results and discussion. By ultrasound characteristics diffuse dyshormonal mammary dysplasia was prevalent among patients of
APA, Harvard, Vancouver, ISO, and other styles
48

O.S., Zotov. "Diffusive non-tumoral pathology of the breast: current state of the problem. Diagnosis and treatment of mastalgia." Reproductive Endocrinology, no. 57 (March 31, 2021): 48–53. https://doi.org/10.18370/2309-4117.2021.57.48-53.

Full text
Abstract:
In the twentieth century, a whole teaching of mastopathy was formed. However, over time, accumulated data have questioned the existence of mastopathy as a separate nosological form, because the term &ldquo;fibrocystic disease&rdquo; while mastalgia is the most common symptom does not correspond to a holistic concept of the disease. This &ldquo;disease&rdquo; can be diagnosed in any woman and more or less successfully treated. In the United States, this term was obsolete in 1985. Instead, the term ANDI (Aberrations in the Normal Development and Involution of the breast) was proposed, which corr
APA, Harvard, Vancouver, ISO, and other styles
49

Lunko, T. A., O. O. Lytvynenko, A. S. Lunko, S. V. Konovalenko, and A. V. Khmel. "Breast cancer is a threatening scenario resulting from the development of endometriosis and benign breast disease overlap syndrome: literature review." INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 21, no. 2 (2025): 206–14. https://doi.org/10.22141/2224-0721.21.2.2025.1520.

Full text
Abstract:
Background. According to the National Cancer Registry of Ukraine, mortality from breast cancer (BC) continues to be at the first places in the structure of oncological pathology among the female population. The overlap syndrome of genital endometriosis (GE) and benign breast disease (BBD) can play a significant role in the development of BC. The purpose: using data from modern literature sources, to consider the overlap syndrome of GE and BBD as a precancerous pattern in the development of BC and outline possible steps to solve the problem. Materials and methods. The search and selection of pu
APA, Harvard, Vancouver, ISO, and other styles
50

Ivanov and Sivkova. "MICROMORPHOLOGICAL CHANGES IN THE ORGANS OF DOGS AFTER THE INFECTION OF DIROFILARIA REPENS." THEORY AND PRACTICE OF PARASITIC DISEASE CONTROL, no. 23 (April 18, 2022): 205–9. http://dx.doi.org/10.31016/978-5-6046256-9-9.2022.23.205-209.

Full text
Abstract:
With the widespread infection of Dirofilaria repens in dogs on the territory of the Russian Federation, the morphological changes in this disease are not well described, and the carcinogenic effect of these helminths on the host has not been established. We have carried out a comprehensive study of morphological changes in the tissues of outbred dogs (the mammary gland of two females and the testes of one male) with subcutaneous dirofilariasis. Excised neoplasms were sent for histological examination, as a result, the females were diagnosed with papillary breast cancer with areas of chondroid
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!